New York State Common Retirement Fund Avrobio, Inc. Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.75 - $1.33 $9,000 - $15,960	-12,000 Reduced 97.4%	320 $0
Q4 2021 Feb 02, 2022	SELL	$3.45 - $6.05 $89 - $157	-26 Reduced 0.21%	12,320 $47,000
Q3 2021 Nov 02, 2021	SELL	$5.53 - $9.28 $89,890 - $150,846	-16,255 Reduced 56.83%	12,346 $69,000
Q2 2021 Aug 02, 2021	BUY	$7.84 - $12.6 $2,359 - $3,792	301 Added 1.06%	28,601 $254,000
Q2 2020 Aug 07, 2020	BUY	$12.19 - $22.96 $124,338 - $234,192	10,200 Added 56.35%	28,300 $494,000
Q3 2019 Nov 07, 2019	BUY	$14.12 - $23.44 $74,836 - $124,232	5,300 Added 41.41%	18,100 $256,000
Q2 2019 Aug 09, 2019	BUY	$13.21 - $27.29 $79,260 - $163,740	6,000 Added 88.24%	12,800 $208,000
Q4 2018 Feb 08, 2019	BUY	$15.43 - $32.7 $104,924 - $222,360	6,800 New	6,800 $113,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.